Home monitoring may keep cancer patients out of the ER

NCT ID NCT05038254

First seen Jun 16, 2026 ยท Last updated Jun 16, 2026

Summary

This study tests whether using telemedicine and remote monitoring can help people with advanced digestive cancers manage chemotherapy side effects at home, reducing the need for emergency room visits and hospital stays. About 750 patients and their caregivers will receive enhanced outpatient support or usual care. The goal is to improve quality of life and keep treatment on track.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE IVC RECTAL CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.

CLINICAL STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE IV ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE IV GASTRIC CANCER AJCC V8 CLINICAL STAGE IVA ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE IVA ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE IVA GASTRIC CANCER AJCC V8 CLINICAL STAGE IVB ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE IVB ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE IVB GASTRIC CANCER AJCC V8 METASTATIC COLON CARCINOMA METASTATIC ESOPHAGEAL CARCINOMA METASTATIC GASTRIC CARCINOMA METASTATIC LIVER CARCINOMA METASTATIC MALIGNANT DIGESTIVE SYSTEM NEOPLASM METASTATIC MALIGNANT SMALL INTESTINAL NEOPLASM METASTATIC MALIGNANT THORACIC NEOPLASM METASTATIC PANCREATIC CARCINOMA METASTATIC RECTAL CARCINOMA PATHOLOGIC STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IV ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IV GASTRIC CANCER AJCC V8 PATHOLOGIC STAGE IVA ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IVA ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IVB ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IVB ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IV ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IV GASTRIC CANCER AJCC V8 POSTNEOADJUVANT THERAPY STAGE IVA ESOPHAGEAL ADENOCARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IVA ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IVB ESOPHAGEAL ADENOCARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IVB ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 STAGE IV COLON CANCER AJCC V8 STAGE IV HEPATOCELLULAR CARCINOMA AJCC V8 STAGE IV PANCREATIC CANCER AJCC V8 STAGE IV RECTAL CANCER AJCC V8 STAGE IV SMALL INTESTINAL, ESOPHAGEAL, COLORECTAL, MESENTERIC, AND PERITONEAL GASTROINTESTINAL STROMAL TUMOR AJCC V8 STAGE IVA COLON CANCER AJCC V8 STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8 STAGE IVA RECTAL CANCER AJCC V8 STAGE IVB COLON CANCER AJCC V8 STAGE IVB HEPATOCELLULAR CARCINOMA AJCC V8 STAGE IVB RECTAL CANCER AJCC V8 STAGE IVC COLON CANCER AJCC V8 STAGE IVC RECTAL CANCER AJCC V8